https://uk.news.yahoo.com/ibuprofen-...1.html#EFgfcT7

just mice and very preliminary. mice live what, 2 years? but interesting.

The team is now preparing for future clinical trials by studying published data from other researchers and looking for inflammation markers in cohorts of patients with age-related diseases such as Parkinson's.

-----------------------------------------
The scientists are now turning their attention to human patients, including one cohort of around 200 people with Parkinson's disease who may be affected by accelerated ageing.

"We need to see which patients do actually have enhanced inflammatory markers before thinking about intervention trials," said Prof von Zglinicki.